Ethic Inc. Guardant Health, Inc. Transaction History
Ethic Inc.
- $5.89 Billion
- Q3 2025
A detailed history of Ethic Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ethic Inc. holds 3,855 shares of GH stock, worth $270,621. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,855
Previous 4,261
9.53%
Holding current value
$270,621
Previous $221,000
8.6%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
419Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$854 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$789 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$349 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$338 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$298 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $7.18B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...